Related Experiment Video
Updated: Jun 20, 2026
06:26
Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease with Fibrosis
Published on: July 18, 2025
Hepatocyte growth factor is elevated in obese adolescents
Christian Jung1, Michael Fritzenwanger, Nicole Fischer
1Friedrich-Schiller-University, Clinic of Internal Medicine I, Jena, Germany. christian.jung@med.uni-jena.de
Journal of Pediatric Endocrinology & Metabolism : JPEM
|September 25, 2009
Summary
Hepatocyte growth factor (HGF) is elevated in overweight adolescents, correlating with obesity metrics. This suggests HGF may link early-life obesity to later health issues.
Area of Science:
- Endocrinology
- Cardiovascular Research
- Pediatric Health
Background:
- Hepatocyte growth factor (HGF) is a key factor in angiogenesis and mitogenesis.
- Elevated HGF levels are associated with vascular diseases and obesity in adults.
Purpose of the Study:
- To determine if HGF levels are altered in obese adolescents.
- To examine the correlation between HGF levels and obesity indicators in this population.
Main Methods:
- Study included 79 male adolescents, with 48% being overweight.
- Collected anthropometric data (BMI, waist circumference) and blood samples.
- Quantified plasma HGF levels using ELISA.
Main Results:
- Overweight adolescents exhibited significantly higher plasma HGF levels compared to controls (p=0.008).
- HGF levels showed a positive correlation with BMI and waist circumference.
- A strong correlation was observed between HGF and high-sensitivity C-reactive protein.
Conclusions:
- Obese adolescents present with elevated levels of Hepatocyte growth factor.
- HGF may represent a crucial link between early-life obesity and the development of associated comorbidities.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:27Signs of Puberty
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...